Michael Van Ameringen

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. doi request reprint Panic attacks in generalized anxiety disorder
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada
    J Nerv Ment Dis 201:52-5. 2013
  2. pmc Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
    Paul D Carey
    MRC Research Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa
    BMC Psychiatry 5:5. 2005
  3. doi request reprint Potential use of Internet-based screening for anxiety disorders: a pilot study
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    Depress Anxiety 27:1006-10. 2010
  4. ncbi request reprint An evaluation of paroxetine in generalised social anxiety disorder
    Michael Van Ameringen
    Anxiety Disorders Clinic, 3G Clinic, McMaster University Medical Centre, Hamilton Health Sciences, Main St W, Hamilton, ON, L8N 3Z5, Canada
    Expert Opin Pharmacother 6:819-30. 2005
  5. ncbi request reprint Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series
    Michael Van Ameringen
    Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
    Depress Anxiety 23:1-5. 2006
  6. ncbi request reprint Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    J Clin Psychiatry 68:288-95. 2007
  7. ncbi request reprint Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    J Psychopharmacol 21:472-6. 2007
  8. doi request reprint The impact of changing diagnostic criteria in posttraumatic stress disorder in a Canadian epidemiologic sample
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, 439 1 Fontbonne Building, St Joseph s Healthcare Hamilton, 301 James St S, Hamilton, Ontario, Canada L8P 3B5
    J Clin Psychiatry 72:1034-41. 2011
  9. ncbi request reprint Pharmacotherapy for social anxiety disorder: an update
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada
    Isr J Psychiatry Relat Sci 46:53-61. 2009
  10. doi request reprint Adult attention deficit hyperactivity disorder in an anxiety disorders population
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    CNS Neurosci Ther 17:221-6. 2011

Research Grants

  1. Improving Outcomes in Pharmacotherapy of Social Phobia
    Michael Van Ameringen; Fiscal Year: 2009
  2. Improving Outcomes in Pharmacotherapy of Social Phobia
    Michael Van Ameringen; Fiscal Year: 2007

Detail Information

Publications33

  1. doi request reprint Panic attacks in generalized anxiety disorder
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada
    J Nerv Ment Dis 201:52-5. 2013
    ..One in five patients with GAD reported GAD panic attacks; however, these individuals did not differ significantly on the correlates that were evaluated. These findings require replication and further evaluation...
  2. pmc Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]
    Paul D Carey
    MRC Research Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa
    BMC Psychiatry 5:5. 2005
    ..Quetiapine is generally well tolerated and previous open-label data has produced mixed results in OCD and additional controlled data is needed...
  3. doi request reprint Potential use of Internet-based screening for anxiety disorders: a pilot study
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    Depress Anxiety 27:1006-10. 2010
    ..We posted a self-report diagnostic screening questionnaire for DSM-IV anxiety and mood disorders (MACSCREEN) on our clinic website...
  4. ncbi request reprint An evaluation of paroxetine in generalised social anxiety disorder
    Michael Van Ameringen
    Anxiety Disorders Clinic, 3G Clinic, McMaster University Medical Centre, Hamilton Health Sciences, Main St W, Hamilton, ON, L8N 3Z5, Canada
    Expert Opin Pharmacother 6:819-30. 2005
    ..The pharmacotherapy of social phobia will be reviewed, with a special focus on investigations with paroxetine...
  5. ncbi request reprint Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series
    Michael Van Ameringen
    Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
    Depress Anxiety 23:1-5. 2006
    ..1 +/- 0.9 to 4.5 +/- 1.3 (P < .001). This case series suggests some preliminary evidence that the addition of topiramate may be useful in treatment-resistant OCD...
  6. ncbi request reprint Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    J Clin Psychiatry 68:288-95. 2007
    ..We evaluated the efficacy, safety, and tolerability of nefazodone, a 5-HT(2) antagonist, in patients with generalized social phobia (GSP)...
  7. ncbi request reprint Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    J Psychopharmacol 21:472-6. 2007
    ..Randomized, double blind, controlled investigations would likely provide useful information as current bioequivalence and pharmacological equivalence do not necessarily translate into clinical equivalence...
  8. doi request reprint The impact of changing diagnostic criteria in posttraumatic stress disorder in a Canadian epidemiologic sample
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, 439 1 Fontbonne Building, St Joseph s Healthcare Hamilton, 301 James St S, Hamilton, Ontario, Canada L8P 3B5
    J Clin Psychiatry 72:1034-41. 2011
    ....
  9. ncbi request reprint Pharmacotherapy for social anxiety disorder: an update
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada
    Isr J Psychiatry Relat Sci 46:53-61. 2009
    ..In this article, treatment studies of pharmacotherapy of social phobia are summarized. Additional issues such as comparative efficacy, treatment resistance and relapse-prevention are reviewed...
  10. doi request reprint Adult attention deficit hyperactivity disorder in an anxiety disorders population
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    CNS Neurosci Ther 17:221-6. 2011
    ..05). The prevalence of adult ADHD was higher in our anxiety disorders clinic sample than found in the general population. Clinical implications of these findings are discussed...
  11. doi request reprint A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    J Clin Psychiatry 71:1336-43. 2010
    ..Trichotillomania has been considered as part of the obsessive-compulsive disorder spectrum; however, trichotillomania treatment with obsessive-compulsive disorder medications has largely been unsuccessful...
  12. doi request reprint Post-traumatic stress disorder in Canada
    Michael Van Ameringen
    Anxiety Disorders Clinic, McMaster University Medical Centre, Department of Psychiatry and Behavioural Neurociences, McMaster University, Hamilton, Ontario, Canada
    CNS Neurosci Ther 14:171-81. 2008
    ..PTSD is a common psychiatric disorder in Canada. The results are surprising, given the comparably low rates of violent crime, a small military and few natural disasters. Potential implications of these findings are discussed...
  13. ncbi request reprint An open trial of topiramate in the treatment of generalized social phobia
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    J Clin Psychiatry 65:1674-8. 2004
    ....
  14. ncbi request reprint Pharmacotherapy of social anxiety disorder at the turn of the millennium
    M Van Ameringen
    Anxiety Disorders Clinic, McMaster University Medical Center, Hamilton Health Sciences, Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
    Psychiatr Clin North Am 24:783-803. 2001
    ..quot; The current established treatments need to be evaluated further in this geriatric population...
  15. ncbi request reprint Topiramate treatment for SSRI-induced weight gain in anxiety disorders
    Michael Van Ameringen
    Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton, ON, Canada
    J Clin Psychiatry 63:981-4. 2002
    ..In this study, topiramate was added to the treatment regimen of patients with a primary DSM-IV anxiety disorder who had experienced substantial SSRI-induced weight gain, in an attempt to induce weight loss...
  16. ncbi request reprint Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study
    M A Van Ameringen
    Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton, Canada
    Am J Psychiatry 158:275-81. 2001
    ..The authors evaluated the efficacy, safety, and tolerability of sertraline, a selective serotonin reuptake inhibitor, in the treatment of generalized social phobia...
  17. ncbi request reprint The impact of anxiety disorders on educational achievement
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont, Canada L8N 3Z5
    J Anxiety Disord 17:561-71. 2003
    ..Further studies are required to determine methods for early identification and treatment of anxiety disorders in school aged children to enable these students to reach their full potential...
  18. ncbi request reprint Predictors of response in generalized social phobia: effect of age of onset
    Michael Van Ameringen
    Anxiety Disorders Clinic, McMaster University Medical Centre, McMaster University, Hamilton, Ontario, Canada
    J Clin Psychopharmacol 24:42-8. 2004
    ..This advantage for later-onset GSP can be accounted for neither by severity of illness nor by duration of illness. Superior treatment outcome for later-onset GSP may be mediated by the degree of social and family disability...
  19. ncbi request reprint WCA recommendations for the long-term treatment of social phobia
    Michael Van Ameringen
    Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
    CNS Spectr 8:40-52. 2003
    ..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months...
  20. ncbi request reprint A PET provocation study of generalized social phobia
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada L8N 3Z5
    Psychiatry Res 132:13-8. 2004
    ..Deactivation of these regions may reflect a strategy of visual avoidance employed by the patients to dampen their phobic experience...
  21. ncbi request reprint Antiepileptic drugs in the treatment of anxiety disorders: role in therapy
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    Drugs 64:2199-220. 2004
    ....
  22. ncbi request reprint Optimizing treatment in social phobia: a review of treatment resistance
    Michael Van Ameringen
    Department of Psychiatry and Behavioural Neurosciences at McMaster University, Hamilton, Ontario, Canada
    CNS Spectr 9:753-62. 2004
    ..Our current treatment target of simply attaining a response needs to be refocused, so that an asymptomatic state and high end state functioning become the final goal of treatment...
  23. doi request reprint Frontal brain oscillatory coupling in children of parents with social phobia: a pilot study
    Vladimir Miskovic
    McMaster Integrative Neuroscience Discovery and Study, McMaster University in Hamilton, Ontario, Canada
    J Neuropsychiatry Clin Neurosci 23:111-4. 2011
    ....
  24. doi request reprint Trichotillomania in youth: a retrospective case series
    Catherine Mancini
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Ontario, Canada
    Depress Anxiety 26:661-5. 2009
    ..The purpose of this study was to investigate the outcome of the naturalistic treatment of youth with Trichotillomania (TTM) in an anxiety disorders clinic sample...
  25. ncbi request reprint Emerging treatments for child and adolescent social phobia: a review
    Catherine Mancini
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    J Child Adolesc Psychopharmacol 15:589-607. 2005
    ..Several studies on the use of cognitive behavioral therapy in youths will also be examined. Practical guidelines for clinicians who treat children and adolescents are also presented...
  26. doi request reprint The prevalence of migraine headaches in an anxiety disorders clinic sample
    Rhandi Senaratne
    Department of Psychology, Faculty of Science, McMaster University, Hamilton, Ontario, Canada
    CNS Neurosci Ther 16:76-82. 2010
    ..Further research is required to better understand the nature and implications of the association between migraine and psychiatric disorders...
  27. ncbi request reprint Does SSRI augmentation with antidepressants that influence noradrenergic function resolve depression in obsessive-compulsive disorder?
    Catherine Mancini
    Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton Health Sciences Corporation, McMaster Site, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5
    J Affect Disord 68:59-65. 2002
    ..However, such is not always the case. We report here on a series of ten patients whose OCD but not depression improved following a trial of SRI therapy...
  28. pmc When too much is not enough: obsessive-compulsive disorder as a pathology of stopping, rather than starting
    Andrea L Hinds
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    PLoS ONE 7:e30586. 2012
    ....
  29. doi request reprint The burden of anxiety disorders on the family
    Rhandi Senaratne
    Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada
    J Nerv Ment Dis 198:876-80. 2010
    ..Health-care professionals should assess the impact of anxiety disorders on the patient's family and provide interventions to reduce burden and improve the quality of life of family members...
  30. ncbi request reprint A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale
    Jonathan Oakman
    Psychology Department, University of Waterloo, Ontario, Canada
    J Clin Psychol 59:149-61. 2003
    ..We argue in favor of adopting the 4-factor model for the LSAS proposed by Safren et al. (1999) instead of the models implied by the scoring instructions for the LSAS...
  31. doi request reprint The psychology of potential threat: properties of the security motivation system
    Andrea L Hinds
    Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1200 Main St W, Hamilton, ON, Canada L8N 3Z5
    Biol Psychol 85:331-7. 2010
    ..These findings are consistent with the hypothesis that deactivation of the security motivation system depends on performance of security-related behaviors, rather than non-behavioral events such as cognitive re-evaluation of threat...
  32. ncbi request reprint Behavioral and psychophysiological characteristics of children of parents with social phobia: a pilot study
    Mira J Campbell
    Department of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, Ontario, Canada
    Int J Neurosci 117:605-16. 2007
    ....
  33. ncbi request reprint Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable?
    Paul D Carey
    Department of Psychiatry, University of Stellenbosch, Tygerberg
    Int Clin Psychopharmacol 27:321-5. 2012
    ..Other factors are, however, also likely to play an important role in predicting outcome...

Research Grants5

  1. Improving Outcomes in Pharmacotherapy of Social Phobia
    Michael Van Ameringen; Fiscal Year: 2009
    ..It thus directly addresses a critical public health issue that adversely affects a substantial proportion of the population. ..
  2. Improving Outcomes in Pharmacotherapy of Social Phobia
    Michael Van Ameringen; Fiscal Year: 2007
    ..It thus directly addresses a critical public health issue that adversely affects a substantial proportion of the population. ..